Get Premium to unlock powerful stock data
NAS:KOD (USA)  
Kodiak Sciences Inc logo

Kodiak Sciences Inc

$ 7.75 +0.11 (+1.44%) 08:08 PM EST
P/E:
At Loss
P/B:
0.67
Market Cap:
$ 402.64M
Enterprise V:
$ -187.69M
Volume:
394.81K
Avg Vol (2M):
981.50K
Also Trade In:
Volume:
394.81K
Market Cap $:
402.64M
PE Ratio:
At Loss
Avg Vol (2-Month):
981.50K
Enterprise Value $:
-187.69M
PB Ratio:
0.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Kodiak Sciences Inc
NAICS : 325412 SIC : 2834
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Description
Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The most advanced product candidate of the group is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Name Current Vs Industry Vs History
Cash-To-Debt 8.25
Equity-to-Asset 0.7
Debt-to-Equity 0.14
Debt-to-EBITDA -0.27
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.17
9-Day RSI 46.7
14-Day RSI 49.39
6-1 Month Momentum % -91.12
12-1 Month Momentum % -92.12

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.94
Quick Ratio 8.94
Cash Ratio 8.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.1
Name Current Vs Industry Vs History
ROE % -43.51
ROA % -32.92
ROIC % -217.48
ROC (Joel Greenblatt) % -330.5
ROCE % -34.91

Financials (Next Earnings Date:2022-08-09 Est.)

KOD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KOD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -6
Beta 2.35
Volatility % 100.19
14-Day RSI 49.39
14-Day ATR ($) 0.592399
20-Day SMA ($) 8.07675
12-1 Month Momentum % -92.12
52-Week Range ($) 4.9 - 131.97
Shares Outstanding (Mil) 51.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kodiak Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More